We addressed growth of biliary atresia (BA) patients living with native livers between ages 0-6 and effects of post-surgical corticosteroid treatment on growth. Growth charts of 28 BA patients born in Finland between 1987 and 2017 were retrospectively evaluated. Dosage and length of corticosteroid treatment and hydrocortisone substitution were reviewed. At birth, BA patients were shorter (median height -0.6 (interquartile range (IQR) -1.3 to -0.1) SDS, n=28, PPeer reviewe
Abstract Aim The role of adjuvant therapy with corticosteroids and choleretics after Kasai portoent...
Introduction: Biliary atresia (BA) represents the leading indication for liver transplantation in ch...
We investigated noninvasive follow-up markers for histologic liver fibrosis and portal hypertension ...
We addressed growth of biliary atresia (BA) patients living with native livers between ages 0-6 and ...
Background/purpose: Biliary atresia is the most common reason for newborn cholestasis and pediatric ...
Publisher Copyright: © 2021 The Author(s)Portoenterostomy (PE) has remained as the generally accepte...
BACKGROUND: Different treatment policies can influence biliary atresia outcomes, but the pathophysio...
Background/purpose: Biliary atresia is the most common reason for newborn cholestasis and pediatric ...
Biliary atresia (BA) is a rare disease of infancy in which obliteration of the biliary tract results...
Objective. The dosage, duration, and the benefits of high-dose steroid treatment and outcome in bili...
Background: Biliary Atresia (BA) is worldwide the leading cause of end-stage liver disease in childr...
ObjectivesTo examine the medical status of children with biliary atresia (BA) with their native live...
SUMMARY Biliary atresia is the leading cause of chronic infantile cholestasis which eventually leads...
AbstractAim: The aim of this systematic review and meta-analysis was to determine if adjunct steroid...
Background: Progression of fibrosis and ensuing complications determine the postoperative course of ...
Abstract Aim The role of adjuvant therapy with corticosteroids and choleretics after Kasai portoent...
Introduction: Biliary atresia (BA) represents the leading indication for liver transplantation in ch...
We investigated noninvasive follow-up markers for histologic liver fibrosis and portal hypertension ...
We addressed growth of biliary atresia (BA) patients living with native livers between ages 0-6 and ...
Background/purpose: Biliary atresia is the most common reason for newborn cholestasis and pediatric ...
Publisher Copyright: © 2021 The Author(s)Portoenterostomy (PE) has remained as the generally accepte...
BACKGROUND: Different treatment policies can influence biliary atresia outcomes, but the pathophysio...
Background/purpose: Biliary atresia is the most common reason for newborn cholestasis and pediatric ...
Biliary atresia (BA) is a rare disease of infancy in which obliteration of the biliary tract results...
Objective. The dosage, duration, and the benefits of high-dose steroid treatment and outcome in bili...
Background: Biliary Atresia (BA) is worldwide the leading cause of end-stage liver disease in childr...
ObjectivesTo examine the medical status of children with biliary atresia (BA) with their native live...
SUMMARY Biliary atresia is the leading cause of chronic infantile cholestasis which eventually leads...
AbstractAim: The aim of this systematic review and meta-analysis was to determine if adjunct steroid...
Background: Progression of fibrosis and ensuing complications determine the postoperative course of ...
Abstract Aim The role of adjuvant therapy with corticosteroids and choleretics after Kasai portoent...
Introduction: Biliary atresia (BA) represents the leading indication for liver transplantation in ch...
We investigated noninvasive follow-up markers for histologic liver fibrosis and portal hypertension ...